{'fraction_non_alphanumeric': 0.03733679919654989, 'fraction_numerical': 0.041738051633484964, 'mean_word_length': 4.838075530263839, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 6, 'lorem ipsum': 0, 'www.': 3, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 1, 'word_list_counts': {'cursed_substrings.json': 6, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A genomic sequence of the type II-A clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated system in Mycoplasma salivarium strain ATCC 29803

ABSTRACT Introduction Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated systems are RNA-mediated adaptive immune systems that actagainst invading genetic elements such as phages or plasmids. CRISPR/Cas systems exist in nearly half of bacteria. Mycoplasma salivarium is a commensal species of the oropharynx. The American Type Culture Collection maintains five M. salivarium strains: ATCC 14277, 23064, 23557, 29803, and 33130. The genome sequence of ATCC 23064 revealed that it has an incomplete CRISPR/Cas system. However, the genome sequences of the remaining strains have not been analyzed. Methods We performed polymerase chain reaction-amplicon sequencing and de novo genome sequencing to evaluate the presence of the CRISPR/Cas system in four strains. Results Only ATCC 29803 possessed cas1, cas2, cas9, and csn2 genes, a CRISPR array, and tracrRNA. The sequences of most components were identical between the CRISPR/Cas systems of ATCC 29803 and ATCC 23064, whereas the spacer sequences and a region of the cas9 gene were different. Unlike the CRISPR/Cas system of ATCC 23064, the cas9 gene of ATCC 29803 was not disrupted by the presence of stop codons. Conclusion ATCC 29803 possesses genomic components required to express the type II-A CRISPR/Cas system, which potentially functions as an RNA-guided endonuclease.


Introduction
The clustered regularly interspaced short palindromic repeats (CRISPR)/ CRISPR associated (Cas) system is an RNA-mediated adaptive immune system that acts against invading genetic elements, such as phages or plasmids. The CRISPR/Cas defense system operates in three phases: 1) adaptation: new spacers are acquired from invading nucleic acids and integrated into the CRISPR array; 2) expression: the CRISPR array is transcribed and processed into small interfering CRISPR RNA (crRNA); 3) interference: crRNAs guide the Cas machinery to specifically cleave homologous invasive nucleic acids [1].
This system consists of a CRISPR array and cas genes [2]. The CRISPR array contains a leader, direct repeats (DRs), and spacers. DRs are highly conserved and tandem short DNA repeats, whereas spacers are unique sequences located at regular intervals between the DRs. Many of these spacers have been matched to sequences, which originate from extra-chromosomal sources, such as phages, plasmids, or other transferable elements, and are termed protospacers. The cas genes encode Cas proteins, which provide the enzymatic machinery required for the acquisition of new spacers from invading genetic elements and for targeting them.
The CRISPR/Cas systems have been reported in 46% of the bacterial species and 82% of the archaea studied [3]. The oral microbiome contains approximately 700 prokaryote species harboring known CRISPR/Cas systems and unidentified CRISPR/Cas systems [4]. Although this system has been classified into six types (type I-VI) based on the signature protein families and features of the cas gene loci architecture [5], oral bacterial CRISPR/Cas systems fall mainly under types I and II [6]. Type I systems contain the signature gene cas3 (or variants of the cas3 gene), while type-II systems are characterized by the presence of cas9, cas1, and cas2 genes [7]. The type-II CRISPR/Cas system has been further classified into three subtypes: A, B, and C. Type II-A systems comprise of the cas1, cas2, and cas9 genes, as well as the csn2 gene, which is a signature gene of this subtype [7]. In contrast, type II-B comprises of the cas4 gene in place of csn2 gene, while type II-C has only three cas genes, cas1, cas2, and cas9 [7].
Mycoplasma spp. are the smallest free-living bacteria capable of self-replication and are characterized by the lack of a bacterial cell wall [8]. At present, 16 species of Mycoplasma have been identified that infect humans. Among them, Mycoplasma pneumoniae, M. salivarium, M. buccale, M. orale, M. faucium, M. lipophilum, and M. fermentans are commensal organisms in the oropharynx [9]. M. salivarium and M. orale are isolated more frequently from the oropharynx than the other Mycoplasma spp [9].
A global survey performed to identify and compare the CRISPR/Cas systems in the genome of Mollicutes reported that complete or degraded systems were found in the genome of 13 out of 35 Mycoplasma spp [10]. All of these 13  The genome size of Mycoplasma spp. is extremely small, ranging from 580 to 1,360 kbp, and the number of protein-coding sequences in the genomes is also small, ranging between 475 and 1,545 in 38 strains from 22 spp. studied [11]. Most Mycoplasma spp. are considered to be parasites and certain Mycoplasma spp. have developed mechanisms to enter host cells that are not naturally phagocytic [8]. Immunohistochemistry and immunoelectron microscopy experiments have shown that M. salivarium often colonizes in the epithelial cells of oral leukoplakia [12,13]. Oral leukoplakia is an oral potentially malignant disorder characterized by various site-specific chromosomal abnormalities and gene alterations in epithelial cells [14][15][16][17]; however, its underlying mechanism has not yet been clarified. The relationship between M. salivarium in epithelial cells and the development and/or progression of oral leukoplakia is also unknown.
In the immune defense mechanism of the type-II CRISPR/Cas systems, the components of the system are first transcribed into trans-activating crRNA (tracrRNA), Cas9 protein, and pre-crRNA. Subsequently, the pre-crRNA is cleaved into crRNA at the site of the DRs by ribonuclease III. Finally, the crRNA-tracrRNA-Cas9 complex forms an active crRNA-guided endonuclease, and the crRNAtargeting sequence binds to a target genomic sequence via complementary RNA-DNA base pairing, after which the DNA is cleaved to form double-strand breaks (DSBs) at the binding site [1]. There has been increasing evidence suggesting that the CRISPR/Cas systems in the human oral microbiome have not only a canonical immune defense mechanism, but also several alternative mechanisms, which can affect bacterial physiological processes such as DNA repair, acquisition of resistance genes, regulation of interspecific competition and intraspecific diversification, and gene expression regulation [6].
Some Mycoplasma spp. are reported to fuse with the host cells under appropriate conditions, and during the fusion process, the functioning of the host cells is affected [8]. Mycoplasma nucleases, which may degrade host cell DNAs, were presumed to be the crucial factor facilitating this process [8]. Electron microscopic observation of M. salivarium cells in epithelial cells signified a fusion between the mycoplasma cells and the cytoplasm of the host cells, and the cell membranes of the mycoplasma cells were not observed in the images [13]. There is a possibility that intracellularly localized M. salivarium affects the host epithelial cells through mechanisms involving the CRISPR/Cas system. Therefore, investigating the CRISPR/Cas system of M. salivarium is worthwhile.
The American Type Culture Collection (ATCC; Manassas, VA, USA) maintains five strains of M. salivarium (ATCC 14277, 23064, 23557, 29803, and 33130) ( Table 1). While the complete genome sequence of ATCC 23064 (NCTC 10113) (accession; NCBI: NZ_LR214939) is available on the NCBI database, the genome sequences of the remaining four ATCC strains have not been analyzed previously. The genome sequence of ATCC 23064 includes genes pertaining to the type-II CRISPR/Cas system, namely the CRISPR array, cas1, cas2, and cas9 genes. A frameshift mutation generates a UAA stop codon in the middle of the cas9 gene sequence, disrupting the cas9 gene. This frame-shift mutation may impair the crRNAguided endonuclease function of cas9.
The CRISPR/Cas systems show considerable variation within species and are not present in all strains of a species. However, when they are present, the number of DRs and spacers varies among the strains in a species [10,[18][19][20][21]. According to the CRISPR database (CRISPRdb) (https://crispr.i2bc.paris-saclay.fr/crispr/), among the 12 strains of M. gallisepticum studied, the number of spacers in the CRISPRs varies between 23 and 105, and the M. canis strain PG 14 possesses a CRISPR containing 7 spacers, whereas strain LV contains two CRISPRs comprising 16 and 18 spacers. It is not known whether the M. salivarium strains ATCC 14277, 23557, 29803, and 33130 possess a CRISPR/Cas system. In this study, we explored these four M. salivarium strains for the presence of the CRISPR/Cas system and investigated the genomic sequences of the CRISPR/Cas systems in these strains.

Culture conditions for M. salivarium strains
Five strains of M. salivarium (ATCC 14277, 23064, 23557, 29803, and 33130) were purchased from the ATCC ( Table 1). ATCC 23064 was used as a positive control for polymerase chain reaction (PCR) amplification and sequencing.
Mycoplasma cells were cultured in ATCC medium 243, which was prepared as described by the ATCC. Heart Infusion Broth (17.5 g; Becton-Dickinson, Franklin Lakes, NJ) was dissolved in deionized water (700 mL) and autoclaved at 121°C for 15 min. Heat-inactivated, sterilized horse serum (200 mL; Merck, Darmstadt, Germany) and yeast extract (100 mL; Oriental Yeast, Tokyo, Japan) were added to the solution aseptically.
Each strain was cultured in the medium at 37°C for 7-10 d under anaerobic conditions. The cells were collected via centrifugation at 11,000 × g for 20 min, washed twice using Dulbecco's phosphatebuffered saline without Ca and Mg (D-PBS; Nacalai Tesque, Kyoto, Japan), and resuspended in D-PBS. Mycoplasma cells were stored in D-PBS at −20°C.

Extraction of genomic DNA from M. salivarium strains
Cells suspended in D-PBS were pelleted via centrifugation at 11,000 × g for 20 min. Genomic DNA was extracted using the Wizard® Genome DNA Purification Kit (Promega, Fitchburg, WI) according to the manufacturer's instructions. Following extraction, the genomic DNA samples were stored at −20°C.

Design of the PCR primers
To amplify the DNA sequences of the CRISPR/Cas system components(, which comprise the CRISPR array, csn2, cas1, cas2, and cas9, and the DNA sequence encoding tracrRNA, several PCR primers (Table 2, Figure 1) were designed based on the complete genome sequence of ATCC 23064 (NCTC 10113) using Primer3Plus software (www.bioinfor matics.nl/cgi-bin/primer3plus/primer3plus.cgi). The primer CAS9 RV2 (Table 2) was designed based on the flanking sequence of the CRISPR array sequence of ATCC 29803, which was slightly different from that of ATCC 23064. The primers were synthesized by Fasmac Co., Ltd. (Atsugi, Kanagawa, Japan).

PCR amplification
The target region sequence was amplified using the KOD One Master Mix (Toyobo, Osaka, Japan). Deionized water (15 µL), 10 mM forward primer (4.5 µL), 10 mM reverse primer (4.5 µL), and approximately 5 ng/µL of genomic DNA (1 µL) were added to the Master Mix (25 µL) for each tube. Amplification was performed using the following thermocycling program: initial template denaturation at 94°C for 2 min; 30 cycles of denaturation, annealing, and extension; and a final elongation step at 68°C for 6 min. The annealing temperature varied according to the melting temperature of the primers and the manufacturer's instructions for the polymerase used. The duration of the denaturation, annealing, and extension processes was determined according to the manufacturer's instructions for the polymerase used.

Sequencing via primer walking
The PCR products were analyzed via electrophoresis on 1% agarose gels. PCR products were purified from the gel slices using NucleoSpin® Gel and PCR Cleanup Kits (Takara Bio Inc., Kusatsu, Japan), according to the manufacturer's instructions. Following extraction, the DNA samples were stored at 0°C until analysis. The PCR products were sequenced via primer walking with paired-end reading, based on segmenting the sequence into several consecutive short sequences [22]. Sequencing was performed by Hokkaido System Science Co., Ltd. (Sapporo, Hokkaido, Japan), using an ABI 3730xl DNA analyzer (Thermo Fisher Scientific, Waltham, MA).

Detection of the CRISPR/Cas system via de novo genome sequencing
In strains in which PCR could not amplify the DNA sequences of the CRISPR/Cas systems, the CRISPR/ Cas systems were analyzed via de novo genome sequencing. For short-read sequencing, the MGEasy FS PCR^Free DNA Library Prep set (MGI Tech, Shenzhen, Guangdong, China) was used for library preparation. Subsequently, 2 × 150 bp paired-end sequencing was performed using a DNBSEQ-G400RS FAST sequencing instrument (MGI Tech) according to the manufacturer's instructions. Raw sequencing data were processed using the FASTQ processing program fastp v. 0.20.1 for trimming low-quality data [23]. Quality-filtered reads were assembled using Unicycler v. 0.4.8. Genome assemblies were annotated automatically using the DNA Databank of DDBJ Fast Annotation and Submission Tool (https://dfast.nig.ac.jp/analysis/annotation). Comparison of multiple genomic regions was visualized using the genome comparison visualizer Easyfig (Easyfig-home (mjsull.github.io)). Sequences with high similarity to the CRISPR array and the csn2, cas1, cas2, or cas9 genes of ATCC 23064 were searched for in the de novo genome assemblies using Basic Local Alignment Search Tool (BLAST). The online CRISPRfinder program (https://crispr.i2bc.parissaclay.fr/Server/) was used to identify CRISPR arrays in the de novo genome assemblies. Since the CRISPR/ Cas system is located between the replicationassociated recombination protein A (rarA) gene and the F0F1 ATP synthase subunit epsilon (ATP5F1E) gene in ATCC 23064, these genes were also analyzed using BLAST to help identify the CRISPR/Cas sequences in the de novo genome sequences. The de novo sequencing and analysis of the genome sequences were performed by the Taniguchi Dental Clinic -Oral Microbiome Center (Takamatsu, Kagawa, Japan).

Comparison of the CRISPR array and cas gene sequences among the strains
The similarity between the CRISPR array and cas gene sequences was analyzed using BLAST followed by Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clus tao/).

Detection of spacers and protospacers
We sought DRs and spacers in the CRISPR using CRISPRfinder and searched for homology to spacers in the genome sequences of phages, plasmids, and viruses to identify the protospacers and their flanking sequences in the databases of Genbank-Phage, RefSeq-Plasmid, and IMG/VR, respectively, using C R I S P R T a r g e t [ h t t p : / / c r i s p r . o t a g o . a c . n z / CRISPRTarget/crispr_analysis.html). Homology to spacers in the genomic sequences of bacteria was identified using BLAST against the NCBI database. The protospacers were defined as sequences with homology that had a maximum of two mismatches out of 30 nucleotides, based on the recommendations of 19.

Prediction of the Cas9 protein sequence
Based on the cas9 gene sequences, the Cas9 protein sequences were predicted using the ExPASy-Translate tool (https://web.expasy.org/cgi-bin/translate/dna2aa. cgi] by using the genetic code of Mycoplasma. The UGA codon serves as a stop codon in most organisms; however, it is translated to tryptophan in Mycoplasma spp [24]. The theoretical molecular weight of the Cas9 protein was computed using ExPASy-Compute pI/Mw (https://web.expasy.org/compute_pi/). Based on the predicted Cas9 protein sequence, the Cas9 protein structure was predicted using SOSUI (http://harrier. nagahama-i-bio.ac.jp/sosui/mobile/).

Detection and prediction of the tracrRNA sequence
The DNA sequence encoding tracrRNA is generally located near the cas genes and contains a stretch with almost perfect homology to a CRISPR DR sequence [25]. We analyzed the regions near the cas genes using BLAST. The RNA sequences transcribed from the DRs and tracrRNA-coding DNA sequences were concatenated to predict the tracrRNA sequence. The secondary structure of the crRNA/tracrRNA hybrid, which was produced from the concatenated RNA sequence, was simulated using the mfold software (http://www.unafold.org/mfold/applications/rnafolding-form.php). The tracrRNA sequence was determined as follows: the region of the sequence bound to the crRNA was estimated to be 21 nucleotides in length, and the length of the tail region was determined based on the secondary structure of a crRNA/tracrRNA hybrid present in M. gallisepticum S6 [10].

Detection of the rnc gene
To identify the rnc genes encoding the RNase III protein, a PCR primer pair, RNC FW and RNC RV ( Table 2), was designed with reference to the genomic sequence of ATCC 23064. The rnc gene sequences were amplified via PCR, and the products were sequenced. The rnc genes were analyzed in the de novo genome sequences.

Identification of the CRISPR/Cas system via PCR amplification and primer walking, or de novo genome sequencing
The DNA sequences of the CRISPR array and the csn2, cas1, cas2, and cas9 gene loci were amplified via PCR for the strains ATCC 23064 and ATCC 29803 (Figures 1  and 2a-c). Subsequently, the sequences of the CRISPR/ Cas system were analyzed via primer walking using PCR products. The CRISPR/Cas system sequences of the strains ATCC 14277, 23557, and 33130 were not amplified using any of the primer pairs shown in Table 2 (Figures 1 and 2a-c), or the other primers. Therefore, de novo genome sequencing was performed for these strains. A summary of the de novo genome assembly of these strains is shown in Table 3. The total genome sequence lengths of ATCC 14277 (accession; DDBJ: BPLV01000001-01000007) and ATCC 23557 (accession; DDBJ: BPLW01000001-01000006) were almost the same, and that of ATCC 33130 (accession; DDBJ: BPLX01000001-01000009) was slightly longer (Table 3). However, the genome size was similar to that of the complete genome sequence of ATCC 23064. Comparison of multiple genomic sequences using BLAST showed high similarity among the three strains and ATCC 23064, as visualized using Easyfig (Figure 3). Although the rarA and ATP5F1E genes were identified in the de novo genome assemblies of three strains with high similarity to that of ATCC 23064, neither the whole, nor partial sequences, of the CRISPR array, csn2, cas1, cas2, or cas9 genes were found in the region between the rarA gene and the ATP5F1E gene, or elsewhere (Figure 3). A CRISPR/Cas system was not found in ATCC 14277, 23557, and 33130.

Identification of the CRISPR sequence in ATCC 29803
The sequences of the CRISPR regions that were amplified using the primer pair CRISPR FW1 and CRISPR RV1 were analyzed via primer walking for ATCC 23064 and ATCC 29803. In ATCC 23064, sequencing of the CRISPR region was performed to confirm PCR amplification and sequencing accuracy. The determined sequence of the CRISPR array of ATCC 23064 (accession; DDBJ: LC633536) was identical to that in the genome sequence of ATCC 23064 available on the NCBI database.
In strains ATCC 23064 and ATCC 29803, the sequences contained 28 copies of a 36 bp DR. The DRs were separated by 30 bp unique sequences. These structures corresponded to the CRISPR comprising DR consensus sequences and regularly interspersed spacer sequences.
The 30 bp unique sequences were separated regularly by DRs, which corresponded to spacers. Most of the spacer sequences were unique in both strains (Tables 4 and 5); however, six repeated spacers were found in ATCC 23064 (Table 4). In ATCC 29803, three repeated spacers were identified (Table 5).
A part of the flanking sequence of the CRISPR of ATCC 29803 showed 100% similarity to the partial cas1 gene sequence of ATCC 23064.
Moreover, a 127 bp sequence was found that was located between the CRISPR and the cas1 gene locus, and adjacent to the first DR. This sequence was as follows.TAAAAACTCCTTATATTTAATT . AGCCATAACATGGCTACATATAATTATAAAG-CAGTTGTTTTAATGCAAAAATTGACTAAAAA-TGCATAAAAATAGCGTTTTTTTGACAAAATC-AACAAAAATGAG. The sequence was identical to that of ATCC 23064 except for one nucleotide, and it appeared to correspond to the leader sequence, which was located adjacent to the first DR and is usually conserved among species [26]. The leader sequence is generally located upstream of the CRISPR [26]; thus, we placed this sequence on the 5′ side of the CRISPR in this study. Therefore, the DNA sequences of the CRISPR array and cas genes of ATCC 29803 were complementary to those in the genome sequence of ATCC 23064 obtained from the NCBI database. The sequences downstream of the CRISPR arrays, the cas9 gene sequences, and the intergenic spacer sequences between the CRISPR array and the cas9 gene locus differed between ATCC 23064 and ATCC 29803.

Identification of the protospacers in the CRISPR of ATCC 29803
For ATCC 29803, spacer homologies with a maximum of two mismatches out of 30 nucleotides were not identified in any phage or plasmid genome sequence. Two spacer sequences, numbers 9 and 12, matched a region of the coding sequences of M. salivarium strains with high similarity ( Table 6). The ninth spacer matched a sequence in the uracil-DNA glycosylase gene of ATCC 23064 with one mismatch and ATCC 14277
The cas9 gene sequence of ATCC 23064 was amplified using the primer pair CAS9 FW1 and CAS9 RV1. In ATCC 29803, this sequence was amplified using the primer pairs CAS9 FW1 and CAS9 RV1, and CAS9 FW1 and CAS9 RV2 (Figures 1 and  2c). In ATCC 14277, 23557, and 33130, the cas9 gene sequences were not amplified via PCR (Figures 1  and 2c).
In ATCC 29803, the sequence of the PCR amplicon generated using the CAS9 FW1 and CAS9 RV2 primer pair was determined. The complete cas9 gene sequence was then obtained via assembly of this sequence and the flanking sequence of the CRISPR array. A region of the cas9 gene sequence was also analyzed via PCR amplification using the primer pair CAS9 FW3 and CAS9 RV3 (Table 2), as shown in Figure 1, and capillary sequencing with paired-end reading. The analyzed sequence (480 bp) completely matched the sequence obtained via primer walking (sequence data are not shown).
The cas9 gene sequences of ATCC 23064 and ATCC 29803 were compared using Clustal Omega (see Supplementary Data 1). Using BLAST, the cas9 sequences were found to show 98% similarity. The unique portion comprised a region of approximately 500 bp that was adjacent to the CRISPR array. The 500 bp sequence of ATCC 29803 showed no significant similarity to that of ATCC 23064. The cas9 of ATCC 23064 is disrupted in the middle of the gene sequence by a frameshift mutation generated by a UAA stop codon. The sequence of ATCC 29803 had no stop codon within the cas9 gene sequence (Supplementary Data 1). Based on the cas9 gene sequence, the Cas9 protein sequence of ATCC 29803 was predicted to contain 1,203 amino acids (Supplementary Data 2). The theoretical molecular weight was 141.0 kDa, and the protein was predicted to be soluble.

Identification of the tracrRNA-coding DNA sequence and prediction of the secondary structure of a crRNA/tracrRNA hybrid in ATCC 29803
A 158 bp DNA sequence encoding tracrRNA (5′-AGTAAGTCCAAAAAATTTATAACTTTTTTAA-TTATACAATTAAAATAAAAATAAAACCCCTA-GATAGGGGCAATTTTGACAGCCTATAAAGGC-GTCTTATTTTAGCGCGTACAATACTTGAGTA-AGCTATAAGTTCTGTACAACTATAATAATAA-CAC-3′) that contained a 36 bp stretch with 88.9% (32/36 bp) homology to a DR sequence, was identified downstream of the cas9 gene locus in ATCC 29803 (Figure 4(a)). This sequence was identical to that of ATCC 23064, except for one nucleotide. The length of the tracrRNA tail was postulated to be 46 nucleotides, and the secondary structure of Table 6. Potential protospacer sequences matched with the spacer sequence in ATCC 29803. the DR/tracrRNA hybrid was predicted to consist of a stem involving the DR and tracrRNA antirepeats, two stem-loops (a nexus stem-loop and a terminator), two linkers, and a poly-uridine tract, similar to the secondary structure of a crRNA/tracrRNA hybrid present in M. gallisepticum S6 [10] (Figure 4(b)). Therefore, assuming that the length of the repeat-derived 3′sequence of crRNA is 22 nucleotides, which is the same length as that of Streptococcus pyogenes crRNA [27], the tracrRNA was predicted to be 67 nucleotides in length, with the following sequence: 5′-AAGUAUUGUACGCGCUAAAAUAA GACGCCUUUAUAGGCUGUCAAAAUUGCCCC-UAUCUAGGGGUUUU-3′ (Figure 4(c)).

Arrangement of the CRISPR/Cas system components in ATCC 29803
The CRISPR/Cas system of ATCC 29803 included the following components: the csn2, cas2, and cas1 genes; the CRISPR array; the cas9 gene; and the tracrRNA, in this order ( Figure 5). This arrangement of the components was identical to that of ATCC 23064 ( Figure 5).

Identification of the rnc gene in ATCC 29803
The rnc gene was amplified in all five strains, yielding products of approximately 400 bp in each case (Figure 2(d)). The sequence of the PCR products of ATCC 29803 (Supplementary data 3) showed 90% similarity to that of ATCC 23064. De novo genome

Discussion
This study investigated the presence and the sequences of the CRISPR/Cas system in four M. salivarium strains: ATCC 14277, 23557, 29803, and 33130. ATCC 23064 was used as a control for PCR amplification and sequencing.
Since PCR amplification could be done in ATCC 23064 and 29803, PCR amplicon sequencing via primer walking with paired-end reading was performed in these strains. The sequence of the CRISPR array of ATCC 23064 obtained using this approach was identical to that available on the NCBI database. Therefore, PCR amplification and sequencing via primer walking yielded sequences with high accuracy. As the CRISPR/Cas system sequences of ATCC 14277, 23557, and 33130 were not amplified via PCR, we performed de novo genome sequencing to search for the CRISPR/Cas system. However, no CRISPR/Cas systems were identified in these strains.
To detect and determine the sequence of the CRISPR/Cas system in this study, we performed PCR amplification and sequencing by primer walking as the initial steps, since primer walking was considered to have a higher accuracy than de novo genome sequencing. However, since whole-genome sequencing is widely being used due to its high accuracy and speed and reduced cost, owing to the advances in the analysis of genome sequences via next-generation sequencing [28], next-generation whole-genome sequencing can be applied to search for CRISPR/Cas systems in Mycoplasma and determine their genomic sequences.
In ATCC 29803, the CRISPR/Cas system comprises the csn2, cas2, and cas1 genes, CRISPR array, cas9 gene, and tracrRNA, in this order. Although the csn2 gene was not annotated in the genome sequence of ATCC 23064, it was designated as csn2 in this study, according to the annotation published by 29. The arrangement of these components was identical to that of ATCC 23064. Therefore, the CRISPR/Cas systems of ATCC 23064 and ATCC 29803 were classified as type II-A systems based on the presence of the cas9, cas1, cas2, and csn2 genes.
CRISPR/Cas systems containing cas9, tracrRNA, cas1, cas2, and a CRISPR array, in this order, are the most common type found in the complete or draft genomes of Mollicutes [10]. However, inversions have been observed in the sequences of several strains, such as M. dispar ATCC 27140, M. ovipneumoniae NM 2010, M. hyosynoviae 232, M. arginini HAZ 145_1, and Mycoplasma arthritidis 158L3_1 [10]. In M. hyosynoviae 232 and M. arthritidis 158L3_1, the CRISPR arrays are located between the cas9 and csn2 gene loci [10]. No Mycoplasma species have been reported to contain the CRISPR/Cas system components in the same order as that of ATCC 23064 and ATCC 29803; however, the implications of this observation are unclear.
The number of DRs has been reported to range from 3-105 in 12 spp. of Mycoplasma studied [10]. Both ATCC 23064 and ATCC 29803 possessed 28 DRs. However, the length of DRs has been found to be 36 bp in 12 Mycoplasma spp [10]. In ATCC 23064 and ATCC 29803, all DRs were also 36 bp in length, except for one DR in ATCC 29803 that was shorter. This short DR was the 26 th DR in a series of 28 DRs. Small differences have been reported to occur; in particular, a repeat at the end of the CRISPR is often truncated or deviates from the consensus sequence [2].
The consensus sequences of all DRs were identical in ATCC 23064, although certain variants were observed in ATCC 29803. However, DR consensus sequences are relatively well-conserved in Mycoplasma species; the following underlined motifs: GTTTTAGCGCTGTACAATATTTGAGTAAGCTA-TAAC are conserved in most Mycoplasma spp [10]. These motifs were also found in the DR consensus sequences of ATCC 23064 and ATCC 29803.
The spacer sequences were unique to each strain and differed between the two strains. The target sequences, which bind to the crRNA-targeting sequences via complementary RNA-DNA base pairing, are different in every spacer when the CRISPR/ Cas system functions as an endonuclease. Although a majority of the spacers are believed to be derived from phages, plasmids, or other organisms, certain CRISPR/Cas systems reportedly possess spacers matching sequences obtained from within the same genome and are called self-targeting spacers [30]. In ATCC 29803, 30 bp sequences corresponding to protospacers were not identified in the genomes of phages, plasmids, or viruses. Instead, certain homologs of spacer sequences were found in the coding sequences of M. salivarium strains ATCC 23064, 14277, 23557, and 33130. However, since the wholegenome sequence of ATCC 29803 was not analyzed, it was not certain whether these homologs were present in its own genome sequence.
It is not rare for a CRISPR-harboring bacterium to possess self-targeting sequences [30]. Although several hypotheses concerning the incorporation of selftargeting spacers and overcoming self-targeting by the CRISPR/Cas system have been reported [30], the mechanisms via which these spacers are acquired and integrated into the genome sequence and how the CRISPR-bearing bacteria survive self-targeting by their own CRISPR/Cas systems are unknown.
For ATCC 23064, the cas9 gene sequence is disrupted in the middle by a frameshift mutation generated by a UAA stop codon. ATCC 29803 had no stop codon within the cas9 gene sequence and the Cas9 protein of ATCC 29803 was predicted to contain 1,203 amino acids. The Cas9 proteins present in Mycoplasma spp. are larger than S. pyogenes Cas9 (1,059 amino acids), but smaller than Staphylococcus aureus Cas9 (1,368 amino acids), with sizes ranging from 1,069 to 1,272 amino acids [10]. The size of the Cas9 protein of ATCC 29803 was within this range, which is considered large enough to be a type-II crRNA-guided endonuclease.
The cas9 gene sequence of ATCC 29803 showed 98% identity to that of ATCC 23064. However, approximately 500 bp of sequence on the CRISPR array side showed no significant similarity to that of ATCC 23064. The Cas9 protein consists of a recognition lobe and a nuclease lobe, which includes several domains. The HNH and RuvC nuclease domains, which are contained in the nuclease lobe, are conserved, whereas the protospacer adjacent motif (PAM)-interacting (PI) domain is variable [31]. Approximately 500 bp of the cas9 gene sequence on the CRISPR array side in ATCC 29803, which was different from that of ATCC 23064, may include the PI domain encoding region. Therefore, when the cas9 gene of ATCC 23064 is not disrupted and coded, Cas9 functions as an endonuclease, and recognizable PAM sequences may differ between the two strains.
It is reported that the Cas9 protein in Mycoplasma spp. is structurally related to the S. aureus Cas9 except for the PI domain, suggesting that various PAMs may be recognized by Cas9 of different Mycoplasma spp [10]. The difference in the sequence of the PI domain between ATCC 23064 and ATCC 29803 may suggest that PAM sequences vary among M. salivarium strains.
The structure of the predicted crRNA/tracrRNA hybrid is conserved and shows typical stem-loop structures among the Mycoplasma spp [10]. Since the tracrRNA sequences were identical between ATCC 23064 and ATCC 29803, the secondary structures of the predicted crRNA/tracrRNA hybrids formed two stem loops, including a nexus stem-loop and a terminator ending, with a poly-uridine tract, in both strains. The rnc genes required by type-II CRISPR/Cas systems to process pre-crRNA to mature crRNA were identified in ATCC 29803 and the other strains. From the above findings, it can be inferred that ATCC 29803 possesses the genomic components necessary to express the type-II CRISPR/Cas system, which potentially functions as an RNA-guided endonuclease.
We restricted this study to the screening of the CRISPR/Cas system and the determination of its sequence in four ATCC strains of M. salivarium. Therefore, the function of the CRISPR/Cas system in ATCC 29803 as an RNA-guided endonuclease was not evaluated.
In conclusion, this study showed that only ATCC 29803 possessed a genomic sequence of the type II-A CRISPR/Cas system among the four M. salivarium strains ATCC 14277, 23557, 29803, and 33130. By comparing the sequences of the CRISPR/Cas systems between ATCC 29803 and ATCC 23064, we found that the sequences were almost similar except for the spacer sequences and regions in the cas9 gene sequence. The spacer sequences are unique to each strain and differed between the two strains. The cas9 gene of ATCC 23064 was disrupted by a UAA stop codon, whereas that of ATCC 29803 lacked a stop codon. The cas9 gene sequence of ATCC 29803 showed 98% identity to that of ATCC 23064. However, approximately 500 bp of the sequence on the CRISPR array side, which contained the PI domain encoding region, showed no similarity to that of ATCC 23064.